Skip to main content
. Author manuscript; available in PMC: 2010 Dec 24.
Published in final edited form as: Chem Biol. 2009 Dec 24;16(12):1278–1289. doi: 10.1016/j.chembiol.2009.11.015

Figure 1. Characterization of the novel β5-specific proteasome inhibitor NC-005.

Figure 1

A Structures of YU-101 and NC-005. B, C. RPMI-8226 cells were treated with YU-101 and NC-005 for 1h and proteasome activity was measured in cells with ProteasomeGlo assay. Mock-treated cells served as control. Values are averages ± S.E. of two experiments.